Impax Laboratories (IPXL) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Selling, general and administrative: 55.04M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 55.04M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q4 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $131.2 million versus the consensus estimate of $125.5 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
